arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Anavex Life Sciences Corp.

AVXL Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$2.55
Today
as of Jul 22, 16:46 ET
Last 30 days +2.00% Jun 12 → Jul 22
$2.31 $2.43 $2.55 $2.67 $2.79 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$2.82
High
$2.82
Low
$2.56
Volume
$941,535
Avg Vol
$2M
Mkt Cap
$224M
P/E (TTM)
—
Beta
—
52w High
$13.99
52w Low
$2.56
Div Yield
—
Shares Out
$93M

Recent Press Releases & News last 60 days · 1 item

Jul 20 · 16:31 MT Newswires
Anavex Life Sciences Submits Plan to Regain Compliance With Nasdaq Timely Filing Rule

Overview

52-week range
$2.56
$14
0% of range
Avg surprise (last 2)
-2.2%
Avg reaction (last 1)
-5.0%
0% positive
Latest IV / EM
150%
EM ±34.3% · $3 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.17$-0.14$-0.12$-0.09$-0.06 Actual $-0.17Actual $-0.14Actual $-0.11Actual $-0.13Actual $-0.14Actual $-0.14Actual $-0.13Est $-0.16Actual $-0.16Est $-0.13Actual $-0.06 MarJunDecMarJunDecMar/2025Jun/2025Dec
Revenue vs Net Income Revenue Net income
$-13M$-11M$-10M$-8M$-6M Mar 24Jun 24Dec 24Mar 25Jun 25Dec 25

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Dec 31, 2025Dec 2025 $-0.06 — — — — financials
Tue Aug 12, 2025Jun/2025 $-0.16 $-0.13 -23.1% — — earnings
Tue May 13, 2025Mar/2025 $-0.13 $-0.16 +18.8% — -5.0% earnings
Tue Dec 31, 2024Dec 2024 $-0.14 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.14 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.13 — — — — financials
Sun Dec 31, 2023Dec 2023 $-0.11 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.14 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.17 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Aug 11, 2026Jun/2026OTHER -$0.08-$0.16 +50.0%

Financials

Income statement (quarterly)

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-7M—$-14M$-13M$-14M—$-15M$-13M
Net income$-6M—$-13M$-11M$-12M—$-12M$-11M
EPS (diluted)$-0.06—$-0.16$-0.13$-0.14—$-0.14$-0.13

Balance sheet (quarterly)

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Cash & equivalents$132M$103M$101M$116M$121M$132M$139M$139M
Inventory————————
Total current assets————————
Total assets$133M$104M$102M$117M$124M$136M$142M$145M
Long-term debt————————
Total liabilities$6M$9M$11M$17M$13M$15M$12M$10M
Total equity$127M$95M$91M$100M$111M$120M$130M$135M

Implied volatility — last 90 days

92%287%481%676%871% Jun 06 — IV 208% · EM ±38.0%Jun 07 — IV 162% · EM ±22.4%Jun 08 — IV 217% · EM ±28.6%Jun 09 — IV 314% · EM ±39.4%Jun 10 — IV 466% · EM ±55.1%Jun 11 — IV 385% · EM ±42.5%Jun 12 — IV 430% · EM ±44.0%Jun 16 — IV 672% · EM ±39.7%Jun 17 — IV 628% · EM ±26.2%Jun 19 — IV 108% · EM ±23.8%Jun 22 — IV 118% · EM ±24.6%Jun 23 — IV 109% · EM ±22.3%Jun 24 — IV 122% · EM ±24.4%Jun 25 — IV 300% · EM ±58.8%Jun 26 — IV 115% · EM ±21.9%Jun 29 — IV 114% · EM ±20.2%Jun 30 — IV 118% · EM ±20.3%Jul 01 — IV 197% · EM ±32.9%Jul 02 — IV 92% · EM ±14.9%Jul 03 — IV 99% · EM ±15.4%Jul 06 — IV 115% · EM ±16.0%Jul 07 — IV 126% · EM ±16.6%Jul 08 — IV 192% · EM ±24.1%Jul 09 — IV 188% · EM ±22.2%Jul 10 — IV 872% · EM ±96.3%Jul 13 — IV 382% · EM ±31.9%Jul 14 — IV 427% · EM ±30.9%Jul 15 — IV 610% · EM ±36.0%Jul 20 — IV 101% · EM ±23.8%Jul 21 — IV 194% · EM ±45.1%Jul 22 — IV 150% · EM ±34.3%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in